Jan. 23 Policy Watch: US Supreme Court will hear Roundup ... - C&EN
In other developments, Congress moves to preserve funding for the NIH, and NOAA issues a final rule on deep seabed mining
cen.acs.orgHere’s a concise update on the latest glyphosate news.
-
Major development: A high-profile retraction of a long-standing safety study for glyphosate has intensified calls for a fresh EPA review of its cancer risk and overall safety. Although the EPA has not changed its stance, lawmakers and advocacy groups are pressing for a reassessment based on newer data and litigation disclosures.[1]
-
Regulatory and litigation context: In the U.S., the EPA continues to evaluate glyphosate under ongoing registration and risk assessments, with independent groups highlighting gaps and urging updates in light of lawsuits and new research. This has kept glyphosate in the public and legal spotlight even as regulatory timelines stretch out.[2][1]
-
International/advocacy angles: Several environmental and public health advocacy outlets are reporting on the broader implications of glyphosate research, including independent toxicology reviews and calls for precautionary action. The coverage ranges from calls for a precautionary pause to discussions about potential regulatory immunity and court cases around Roundup.[3][5]
-
Notable contemporary voices and sources: Media coverage has included mainstream outlets detailing retractions and the ensuing policy debates, while trade and advocacy sites emphasize ongoing controversy and calls for stronger oversight of glyphosate-related products and related herbicides.[4][1][3]
-
Related regulatory signals: There are ongoing discussions around the role of major stakeholders (e.g., Bayer) in litigation strategies and how those dynamics intersect with regulatory reviews, as well as broader coverage of pesticide safety in relation to crops and consumer exposure.[5][2][3]
If you’d like, I can pull the most recent headlines from a specific region (e.g., EU, Canada, Denmark) or summarize key regulatory positions from major agencies (EPA, EFSA, Health Canada) with direct quotes. Please tell me which scope you prefer.
Citations:
- NYT coverage on retraction and EPA reassessment calls.[1]
- No-Till Farmer roundup and EPA review context.[2]
- GMWatch synthesis on regulatory and legal developments.[3]
- CBC report on retraction and Health Canada response.[4]
- GMWatch latest findings and legal context.[5]